Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
TD SYNNEX $600 million senior notes offering
The investment-grade notes are due 2034
Nippon Life Insurance $1.32 billion subordinated notes offering
We advised Nippon Life on its offering of step-up callable subordinated notes
Nurix Therapeutics $175 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Ultra Clean Holdings $500 million term loan facilities and related amendments
We advised the borrower on the transaction
Nuveen $1.25 billion senior notes offering
We advised Nuveen on the investment-grade debt offering
SoundHound AI $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Toronto-Dominion Bank $500 million notes offering
The investment-grade notes are due 2025
Arrow Electronics $500 million senior notes offering
The 5.875% investment-grade senior notes are due 2034
TD SYNNEX $606 million secondary offering
The shares are listed on the NYSE
Biodesix $55 million follow-on offering
The common stock is listed on the Nasdaq Global Market